Updated on: November 17, 2020 11:34 IST

Good News: American company Moderna Completes Enrollment of Phase 3 of COVID vaccine

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that it has completed enrollment of 30,000

Latest Videos